chemokin
play
pivot
role
innat
respons
bacteri
viral
infect
mix
infect
determin
chemokin
respons
sindbi
viru
sin
coinfect
model
peripher
blood
mononuclear
cell
pbmc
deriv
healthi
volunt
expos
sin
presenc
absenc
lipopolysaccharid
lp
cultur
supernat
recov
h
postexposur
evalu
viru
replic
analyz
chemokin
elisa
none
pbmc
cultur
show
new
viru
releas
gfp
report
express
viral
rna
synthesi
sin
littl
effect
induct
rant
chemokin
p
p
drastic
upregul
sin
well
lp
live
uvinactiv
sin
induc
secret
itac
although
lp
induc
releas
sharpli
inhibit
p
sinmedi
secret
contrari
releas
slc
block
sin
adjuv
activ
antiangiogen
function
antagon
sin
lp
releas
select
chemokin
may
use
understand
pathogenesi
mix
infect
crosstalk
cellular
pathway
may
applic
cancer
sepsi
h
uman
often
expos
multipl
bacteri
viral
agent
simultan
infect
one
agent
make
host
suscept
agent
exampl
hivinfect
patient
bacteri
fungal
viral
infect
lead
multipl
complic
similarli
infect
influenza
viru
predispos
respiratori
tract
bacteri
infect
lead
heighten
morbid
mix
infect
may
lead
activ
multipl
cellular
receptor
signal
pathway
may
synerg
antagon
innat
adapt
immun
mechan
sindbi
viru
one
best
studi
mosquitotransmit
rna
virus
occasion
caus
fever
arthralgia
human
much
milder
chikungunya
arthriti
geneticallyengin
rna
genom
alphavirus
includ
sindbi
viru
sin
semliki
forest
viru
sfv
venezuelan
equin
enceph
viru
vee
extens
use
viral
vector
oncolyt
agent
use
mous
model
inflammatori
respons
includ
type
interferon
tnfa
ifng
alphavirus
well
studi
strikingli
chemokin
appear
contribut
alphaviru
pathogenesi
arthralgia
present
work
examin
chemokin
respons
human
peripher
blood
mononuclear
cell
pbmc
sin
exposur
bacteri
compon
lipopolysaccharid
lp
one
best
studi
ligand
inflamm
research
lp
downregul
interferon
induct
block
virusinduc
phosphoryl
hypothes
lp
might
alter
sininduc
chemokin
releas
vice
versa
knowledg
may
shed
light
pathogenesi
mix
infect
chemokin
famili
small
secret
protein
mediat
inflamm
angiogenesi
lymphocyt
traffick
group
four
subfamili
c
cc
cxc
base
locat
ntermin
cystein
residu
chemokin
receptor
multitud
gprotein
coupl
receptor
type
receptor
bind
sever
chemokin
chemokin
bind
one
receptor
bacteri
viral
infect
induc
common
distinct
chemokin
cxc
chemokin
induc
type
type
ii
interferon
secret
monocyt
cell
type
addit
bacteri
viral
infect
express
high
level
autoimmun
disord
sinc
alphavirus
import
caus
arthralgia
studi
virusinduc
chemokin
express
may
relev
howev
regul
induct
mix
infect
modifi
diseas
outcom
unclear
robust
sin
replic
occur
varieti
vertebr
cell
type
insect
cell
cultur
although
human
pbmc
lymphoid
tissu
known
refractori
sin
replic
viru
adapt
replic
human
dendrit
cell
human
macrophag
recent
shown
infect
sindbi
strain
previou
work
other
indic
signific
innat
respons
virus
absenc
replic
present
work
show
differenti
chemokin
induct
sin
pinpoint
antagon
releas
select
chemokin
lp
possibl
mechan
applic
find
also
discuss
knowledg
first
report
sinmedi
induct
pbmc
absenc
viru
replic
cell
cultur
bhk
vero
cell
maintain
minim
essenti
medium
invitrogen
carlsbad
ca
contain
fetal
bovin
serum
bhk
cell
use
transfect
vitro
transcrib
rna
vero
cell
use
product
titrat
sin
stock
unless
specifi
reagent
purchas
invitrogen
vitro
transcript
sin
singfpt
done
describ
earlier
fig
approxim
mg
sin
singfpt
linear
new
england
biolab
ipswich
subsequ
ethanol
precipit
dissolv
depctreat
water
linear
plasmid
transcrib
vitro
use
rna
polymeras
ml
transcript
mix
contain
mm
ntp
mm
dtt
cap
analog
transcript
mixtur
incub
h
subsequ
dnase
treatment
phenolchloroform
extract
rna
precipit
wash
ethanol
dissolv
depctreat
water
store
confluent
bhk
cell
tissu
cultur
dish
transfect
ml
transfect
mixtur
contain
mg
transcrib
rna
ml
lipofectin
plate
continu
rock
min
room
temperatur
min
transfect
mixtur
remov
ml
prewarm
mem
contain
fetal
bovin
serum
gentamicin
mgml
ad
cell
incub
continu
cell
observ
cytopath
effect
cellfre
cultur
supernat
recov
h
store
stock
sin
singfpt
virus
prepar
vero
bhk
cell
infect
moi
incub
h
viru
seed
prepar
clarifi
infecti
cell
cultur
media
centrifug
store
aliquot
viru
purifi
ultracentrifug
cultur
fluid
h
k
rpm
sucros
cushion
sucrosecushion
purifi
parent
viru
prepar
behav
similarli
uvinactiv
viru
particl
carri
biorad
uvchamb
program
biorad
hercul
ca
endotoxin
test
viru
prepar
carri
use
kinet
chromogen
assay
kit
use
lal
reagent
charl
river
laboratori
wilmington
per
manufactur
protocol
found
less
pfu
viru
uvinactiv
viru
equival
viral
titer
determin
plaqu
assay
serial
dilut
viru
stock
vero
cell
monolay
infecti
viru
detect
even
undilut
uvinactiv
viru
prepar
healthi
volunt
recruit
studi
approv
protocol
institut
review
board
irb
meharri
medic
colleg
peripher
blood
collect
heparin
tube
pbmc
separ
densiti
gradient
centrifug
use
ficollpaqu
plu
wash
hbss
pbmc
cultur
medium
supplement
mm
glutamax
contain
autolog
plasma
concentr
cellsml
plate
cell
viabil
check
use
trypan
blue
dye
exclus
test
cell
viabl
fresh
pbmc
collect
healthi
subject
stimul
sin
lp
imgenex
san
diego
ca
vitro
induc
chemokin
product
secret
cultur
supernat
fluid
briefli
pbmc
ml
treat
singfpt
sin
moi
orand
e
coli
lp
mgml
maintain
h
co
supernat
collect
cell
cultur
h
incub
co
clarifi
centrifug
frozen
later
chemokin
viral
plaqu
assay
singfpteinfect
cell
remov
cold
phosphatebuff
salin
pb
ph
wash
stain
surfac
marker
analyz
flow
cytometri
parallel
mosquito
cell
also
infect
singfpt
moi
h
co
observ
fluoresc
microscopi
surfac
stain
pbmc
infect
singfpt
done
determin
sinspecif
rna
synthesi
gfp
express
h
use
apcconjug
antibodi
antibodi
peconjug
antibodi
monocyt
stain
antibodi
bd
bioscienc
pharmingen
franklin
lake
nj
stain
cell
wash
pb
fix
pfa
acquir
facscalibur
flow
cytomet
scatter
pattern
event
count
lymphocyteand
monocyteg
region
analyz
use
cellquest
pro
softwar
pgml
pgml
pgml
minim
interassay
variabl
measur
sampl
studi
subject
assay
respect
chemokin
elisa
plate
day
assay
determin
viral
titer
pbmc
supernat
collect
h
serial
dilut
use
infect
vero
cell
monolay
h
infect
viral
suspens
remov
monolay
overlay
nobl
agar
mem
incub
h
cell
observ
appear
plaqu
stain
crystal
violet
plaqu
count
differ
mean
cytokin
level
compar
use
pair
student
ttest
nonparametr
wilcoxon
sign
rank
test
wherev
applic
use
microsoft
excel
graphpad
prism
result
express
arithmet
mean
ae
standard
error
p
valu
set
level
signific
determin
sin
replic
pbmc
use
infecti
viru
deriv
engin
express
plasmid
fig
pbmc
cultur
supernat
expos
sin
analyz
viral
plaqu
assay
except
amount
input
viru
addit
viru
releas
h
demonstr
data
shown
parallel
pbmc
cultur
expos
engin
sin
encod
gfp
report
protein
singfpt
fig
cell
analyz
flow
cytometri
gfp
fluoresc
observ
pbmc
popul
test
fig
high
level
gfp
express
observ
infect
cell
fig
result
indic
defect
rna
synthesi
viru
releas
pbmc
expos
sin
presenc
absenc
lp
determin
virusspecif
rna
pbmc
quantit
pcr
also
indic
lack
accumul
virusspecif
rna
fig
low
releas
observ
h
cultur
condit
fig
howev
h
lpsa
well
sin
lpstreat
cultur
show
high
level
result
suggest
sin
antagon
lpsinduc
releas
level
rant
compar
time
point
infect
uninfect
cultur
fig
howev
h
lpstreat
sin
lpstreat
cultur
show
significantli
higher
level
p
p
rant
suggest
lpsinduc
rant
level
unalt
sin
coexposur
dhanushkodi
et
al
sin
well
lp
stimul
h
neglig
amount
detect
cultur
supernat
fig
howev
h
moder
high
level
releas
sin
lp
sin
lp
p
treat
cultur
data
suggest
nonantagon
pathway
lp
sin
upregul
releas
shown
fig
even
h
high
level
secret
lpsand
sin
lpstreat
p
cultur
h
three
treat
cultur
releas
high
p
amount
wherea
control
cultur
releas
low
level
result
suggest
delay
sininduc
secret
compar
lp
similarli
high
level
p
found
treat
cultur
h
fig
chemokin
itac
interact
receptor
shown
fig
littl
detect
h
cultur
howev
h
significantli
high
level
p
induc
sin
although
lp
induc
drastic
p
block
sininduc
releas
interestingli
itac
induct
sin
also
block
lp
fig
suggest
involv
common
pathway
time
point
test
control
lpstreat
cultur
express
moder
amount
slc
fig
howev
sin
effect
block
releas
slc
presenc
absenc
lp
tabl
summar
chemokin
analyz
lp
sin
influenc
secret
parallelantagonist
manner
shown
fig
level
induct
high
even
moi
sin
exposur
twofold
increas
could
achiev
moi
interestingli
even
uvinactiv
sin
induc
compar
level
indic
viru
replic
pbmc
requir
induct
fig
remark
monophosphoryl
lipid
mpl
lp
deriv
use
vaccin
adjuv
inhibit
virusinduc
secret
fig
observ
suggest
chemic
moieti
within
lp
may
respons
inhibit
induct
sin
present
work
determin
induct
select
set
chemokin
pbmc
expos
sin
prelud
understand
virusinduc
human
innat
respons
express
pattern
chemokin
receptor
import
biomark
infect
polar
immun
respons
level
found
sinexpos
pbmc
cultur
appear
correl
observ
mous
model
viru
infect
releas
chemokin
sinexpos
pbmc
absenc
signific
viru
replic
mirror
result
obtain
envelop
virus
absenc
gfp
report
express
new
viral
rna
synthesi
determin
qpcr
viral
particl
releas
also
suggest
poor
replic
engin
sin
pbmc
result
chemokin
respons
pbmc
sin
particl
absenc
replic
reminisc
envelop
viru
particlemedi
innat
respons
observ
cultur
fibroblast
induct
chemokin
viral
particl
may
type
ifndepend
independ
also
appear
celltyp
specif
use
sensit
mrnptag
system
konopka
et
al
report
induct
mous
dendrit
cell
anoth
alphaviru
infect
depend
ifnab
signal
howev
rna
virus
induc
synthesi
absenc
type
ifn
product
viru
replic
fibroblast
tlr
mechan
propos
viral
particlemedi
innat
immun
respons
express
ifna
cytokin
human
pbmc
expos
uvinactiv
virus
indic
immun
activ
although
express
report
addit
ifng
ifna
also
induc
synthesi
lp
inhibit
virusmedi
ifna
gene
express
human
fibroblast
experi
pbmc
expos
sin
readili
produc
ifna
also
block
lp
howev
ifng
releas
sin
unpublish
data
therefor
appear
ifna
signal
could
account
induct
pbmc
expos
sin
sinc
lp
block
sininduc
releas
notabl
proost
et
al
report
express
human
pbmc
induc
dsrna
induct
block
lp
present
experi
releas
occur
absenc
signific
rna
replic
dsrna
may
induc
indic
previous
fibrobalst
viru
particlemedi
immun
respons
appear
account
chemokin
releas
pbmc
sin
remain
establish
viral
capsid
protein
induc
activ
nfkb
shown
adenoviru
viral
bacteri
coinfect
alter
immun
respons
multipl
way
may
exploit
biomedicin
signal
pathway
involv
host
respons
viral
bacteri
pathogen
also
appear
overlap
use
lp
tlr
ligand
sin
infect
may
help
unravel
signal
crosstalk
differ
pathway
viral
rna
recogn
cytoplasm
helicas
agonist
recent
report
downregul
polymicrobi
sepsi
suggest
viral
infect
might
protect
effect
bacteri
toxic
adjuv
activ
induct
sin
may
strengthen
use
sin
particl
vaccin
deliveri
applic
inhibit
angiogenesi
may
partli
explain
activ
pursu
oncolyt
activ
sin
therebi
promot
potenti
use
cancer
therapeut
